New hope for kids with rare blood vessel disease: avacopan trial launches
NCT ID NCT06321601
First seen Jun 25, 2026 · Last updated Jul 21, 2026 · Updated 3 times
Summary
This study tests whether the drug avacopan can help children aged 6 to 18 with a rare autoimmune disease called ANCA-associated vasculitis, which causes inflammation of blood vessels. About 20 participants will receive avacopan alongside standard treatments like rituximab or cyclophosphamide. The main goal is to see if the disease goes into remission by 26 weeks and stays under control for a year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- avacopan (a drug that blocks inflammation, taken by mouth)
- What this could lead to
- If successful, this could provide a new treatment option for children with this rare autoimmune disease, potentially reducing the need for steroids.
- What could go wrong
- This is a small, single-arm study with no placebo group, so results may be less reliable. Avacopan may cause side effects like infections or liver issues.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANCA-ASSOCIATED VASCULITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Akron Childrens Hospital
Akron, Ohio, 44308, United States
-
Alberta Childrens Hospital
Calgary, Alberta, T3B 6A8, Canada
-
British Columbia Childrens Hospital
Vancouver, British Columbia, V6H 3N1, Canada
-
CHU Sainte Justine
Montreal, Quebec, H3T 1C5, Canada
-
Centre Hospitalier Universitaire de Bordeaux - Hopital Pellegrin
Bordeaux, 33076, France
-
Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
-
Cohen Children Medical Center
Lake Success, New York, 11042, United States
-
Dzieciecy Szpital Kliniczny im. Jozefa Polikarpa Brudzinskiego w Warszawie
Warsaw, 02-091, Poland
-
Emory University
Atlanta, Georgia, 30322, United States
-
Erciyes Universitesi Tip Fakultesi Hastanesi
Kayseri, 38030, Turkey (Türkiye)
-
Fakultni nemocnice Motol a Homolka
Prague, 150 06, Czechia
-
Hacettepe Universitesi Tip Fakultesi Hastanesi
Ankara, 06100, Turkey (Türkiye)
-
Hopital Necker
Paris, 75015, France
-
Hopital Necker Enfants Malades
Paris, 75015, France
-
Hospices Civils de Lyon Hopital Femme Mere Enfant
Bron, 69677, France
-
Hospital Sant Joan de Deu
Esplugues de Llobregat, Catalonia, 08950, Spain
-
Hospital Universitari Vall d Hebron
Barcelona, Catalonia, 08035, Spain
-
Hospital Universitario 12 de Octubre
Madrid, 28041, Spain
-
Narodny ustav detskych chorob
Bratislava, 833 40, Slovakia
-
Riley Hospital for Children
Indianapolis, Indiana, 46202, United States
-
Semmelweis Egyetem
Budapest, 1094, Hungary
-
Stollery Childrens Hospital
Edmonton, Alberta, T6G 1C9, Canada
-
Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont Altalanos Orvostudomanyi Kar
Szeged, 6720, Hungary
-
Texas Childrens Hospital
Houston, Texas, 77030, United States
-
Umraniye Egitim ve Arastirma Hastanesi
Istanbul, 34764, Turkey (Türkiye)
-
Universitair Ziekenhuis Gent
Ghent, 9000, Belgium
-
Universitair Ziekenhuis Leuven - Gasthuisberg
Leuven, 3000, Belgium
-
University of Minnesota Masonic Childrens Hospital Discovery Clinic
Minneapolis, Minnesota, 55454, United States
-
University of North Carolina
Chapel Hill, North Carolina, 27599, United States
-
University of Pittsburgh Medical Center Childrens Hospital of Pittsburgh
Pittsburgh, Pennsylvania, 15224, United States
-
Uniwersytecki Szpital Dzieciecy w Krakowie
Krakow, 30-663, Poland
-
Uniwersyteckie Centrum Kliniczne
Gdansk, 80-952, Poland
-
Vseobecna fakultni nemocnice v Praze
Prague, 128 08, Czechia
-
Wake Forest University Health Sciences
Charlotte, North Carolina, 28203, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Immune clues in the blood may foretell heart trouble
- Can a new drug tame vasculitis with fewer side effects?
- Engineered immune cells take aim at autoimmune kidney diseases
- Could a diabetes drug shield kidneys from autoimmune attack?
- Scientists probe kidney cell metabolism to unlock secrets of ANCA vasculitis
- New tool could predict who will suffer from steroid side effects